Dottikon Es Stock
StockStockPrice
Frequently asked questions
What is Dottikon Es's market capitalization?
What is Dottikon Es's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Dottikon Es?
What are the analyst ratings and target price for Dottikon Es's stock?
What is Dottikon Es's revenue over the trailing twelve months?
What is the EBITDA for Dottikon Es?
What is the free cash flow of Dottikon Es?
What is the 5-year beta of Dottikon Es's stock?
How many employees does Dottikon Es have, and what sector and industry does it belong to?
What is the free float of Dottikon Es's shares?
Financials
Market Cap
$3.79B5Y beta
1.87EPS (TTM)
$6.578Free Float
3.90MP/E ratio (TTM)
41.13Revenue (TTM)
$367.76MEBITDA (TTM)
$124.50MFree Cashflow (TTM)
-$64.74MPricing
Analyst Ratings
The price target is and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.
726
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker